Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Shares Outstanding (2010 - 2026)

Geron (GERN) posted Shares Outstanding (Entity) of $669375.0 for Q1 2026, down 99.9% sequentially from $639.9 million in Q4 2025, and down 99.89% YoY from $636.9 million in Q1 2025.

Geron (GERN) Shares Outstanding (2010 - 2026) Analysis & Trends

Geron has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $669375.0 in Q1 2026.

  • Quarterly Shares Outstanding (Entity) fell 99.89% year-over-year to $669375.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $669375.0 (down 99.89% YoY) and the FY2025 annual result came in at $639.9 million, up 5.52% from the prior year.
  • Shares Outstanding (Entity) declined to $669375.0 in Q1 2026 per GERN's latest filing, from $639.9 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $639.9 million in Q4 2025 and troughed at $669375.0 in Q1 2026.
  • A 5-year average of $506.3 million and a median of $544.9 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) jumped 42.45% in 2023, then tumbled 99.89% in 2026.
  • Over 5 years, Shares Outstanding (Entity) stood at $390.3 million in 2022, then soared by 39.63% to $544.9 million in 2023, then climbed by 11.28% to $606.4 million in 2024, then advanced by 5.52% to $639.9 million in 2025, then tumbled by 99.9% to $669375.0 in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $669375.0, $639.9 million, and $638.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.19 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 445.06 Mn
10 Geron 1.02 Mn -299.83 Mn - 670,696.00

Historic Data

Download Data
DateValue
Jun 30, 2026 670,696.00
Mar 31, 2026 669,375.00
Dec 31, 2025 666.66 Mn
Sep 30, 2025 667.10 Mn
Jun 30, 2025 666.17 Mn
Mar 31, 2025 665.91 Mn
Dec 31, 2024 646.03 Mn
Sep 30, 2024 662.16 Mn
Jun 30, 2024 653.90 Mn
Mar 31, 2024 603.49 Mn
Dec 31, 2023 570.65 Mn
Sep 30, 2023 579.51 Mn
Jun 30, 2023 547.28 Mn
Mar 31, 2023 544.46 Mn
Dec 31, 2022 380.78 Mn
Sep 30, 2022 405.24 Mn
Jun 30, 2022 403.87 Mn
Mar 31, 2022 332.07 Mn
Dec 31, 2021 327.63 Mn
Sep 30, 2021 328.93 Mn